These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24074231)

  • 41. Hypoglycaemic activity of Pterocarpus marsupium Roxb.
    Dhanabal SP; Kokate CK; Ramanathan M; Kumar EP; Suresh B
    Phytother Res; 2006 Jan; 20(1):4-8. PubMed ID: 16397913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Pterocarpus santalinus bark, on blood glucose, serum lipids, plasma insulin and hepatic carbohydrate metabolic enzymes in streptozotocin-induced diabetic rats.
    Kondeti VK; Badri KR; Maddirala DR; Thur SK; Fatima SS; Kasetti RB; Rao CA
    Food Chem Toxicol; 2010 May; 48(5):1281-7. PubMed ID: 20178824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).
    Thornberry NA; Gallwitz B
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):479-86. PubMed ID: 19748065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus.
    Sharma SB; Nasir A; Prabhu KM; Murthy PS
    J Ethnopharmacol; 2006 Apr; 104(3):367-73. PubMed ID: 16386863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats.
    Kar A; Choudhary BK; Bandyopadhyay NG
    J Ethnopharmacol; 2003 Jan; 84(1):105-8. PubMed ID: 12499084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetic therapeutic effects of ethyl acetate fraction from the roots of Musa paradisiaca and seeds of Eugenia jambolana in streptozotocin-induced male diabetic rats.
    Panda DK; Ghosh D; Bhat B; Talwar SK; Jaggi M; Mukherjee R
    Methods Find Exp Clin Pharmacol; 2009 Nov; 31(9):571-84. PubMed ID: 20094640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery.
    Chae SY; Jin CH; Shin HJ; Youn YS; Lee S; Lee KC
    Bioconjug Chem; 2008 Jan; 19(1):334-41. PubMed ID: 18078308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
    Vaghela M; Sahu N; Kharkar P; Pandita N
    Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-cataract activity of Pterocarpus marsupium bark and Trigonella foenum-graecum seeds extract in alloxan diabetic rats.
    Vats V; Yadav SP; Biswas NR; Grover JK
    J Ethnopharmacol; 2004 Aug; 93(2-3):289-94. PubMed ID: 15234767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure.
    Asakawa T; Moritoh Y; Kataoka O; Suzuki N; Takeuchi K; Odaka H
    Life Sci; 2009 Jul; 85(3-4):122-6. PubMed ID: 19427871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory potential of traditional herbs on α-amylase activity.
    Saha S; Verma R
    Pharm Biol; 2012 Mar; 50(3):326-31. PubMed ID: 22136147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.
    Kim SJ; Nian C; Doudet DJ; McIntosh CH
    Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and Discovery of Novel 1,3,5-Triazines as Dipeptidyl Peptidase-4 Inhibitor against Diabetes.
    Wang Y; Tang X; Yi L
    Pharmacology; 2019; 103(5-6):273-281. PubMed ID: 30799431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-linear increase in GLP-1 levels in response to DPP-IV inhibition in healthy adult subjects.
    Dai H; Gustavson SM; Preston GM; Eskra JD; Calle R; Hirshberg B
    Diabetes Obes Metab; 2008 Jun; 10(6):506-13. PubMed ID: 18284437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha-amylase inhibitory activity of two Anthocleista species and in vivo rat model anti-diabetic activities of Anthocleista djalonensis extracts and fractions.
    Olubomehin OO; Abo KA; Ajaiyeoba EO
    J Ethnopharmacol; 2013 Apr; 146(3):811-4. PubMed ID: 23422334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes.
    Lindsay JR; Duffy NA; McKillop AM; Ardill J; O'Harte FP; Flatt PR; Bell PM
    Diabet Med; 2005 May; 22(5):654-7. PubMed ID: 15842525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats.
    Freyse EJ; Berg S; Kohnert KD; Heinke P; Salzsieder E
    Biol Chem; 2011 Mar; 392(3):209-15. PubMed ID: 21281062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular effects of DPP-4 inhibition: beyond GLP-1.
    Fadini GP; Avogaro A
    Vascul Pharmacol; 2011; 55(1-3):10-6. PubMed ID: 21664294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Research progress of mechanisms through which dipeptidyl peptidase-4 inhibitors regulate glycemia].
    Wang JS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):229-33. PubMed ID: 23643015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.